Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| lung | 18 studies | 37% ± 17% | |
| peripheral blood | 17 studies | 43% ± 14% | |
| intestine | 11 studies | 39% ± 21% | |
| brain | 9 studies | 23% ± 6% | |
| eye | 8 studies | 31% ± 17% | |
| kidney | 7 studies | 41% ± 16% | |
| lymph node | 6 studies | 45% ± 16% | |
| liver | 6 studies | 33% ± 22% | |
| pancreas | 5 studies | 32% ± 14% | |
| uterus | 5 studies | 45% ± 17% | |
| placenta | 4 studies | 38% ± 21% | |
| bone marrow | 4 studies | 36% ± 15% | |
| breast | 4 studies | 50% ± 11% | |
| adrenal gland | 3 studies | 38% ± 12% | |
| esophagus | 3 studies | 45% ± 32% | |
| skin | 3 studies | 40% ± 16% | |
| prostate | 3 studies | 49% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 7842.96 | 1445 / 1445 | 100% | 46.38 | 183 / 183 |
| ovary | 100% | 12745.33 | 180 / 180 | 100% | 75.21 | 430 / 430 |
| pancreas | 100% | 4168.77 | 328 / 328 | 100% | 64.53 | 178 / 178 |
| stomach | 100% | 6708.81 | 359 / 359 | 100% | 62.92 | 286 / 286 |
| lung | 100% | 8480.11 | 578 / 578 | 100% | 61.87 | 1154 / 1155 |
| intestine | 100% | 8271.82 | 966 / 966 | 100% | 69.75 | 526 / 527 |
| prostate | 100% | 7003.12 | 245 / 245 | 100% | 78.92 | 501 / 502 |
| skin | 100% | 8968.98 | 1809 / 1809 | 100% | 67.34 | 471 / 472 |
| uterus | 100% | 10884.75 | 170 / 170 | 100% | 91.09 | 458 / 459 |
| thymus | 100% | 8337.02 | 653 / 653 | 100% | 89.81 | 603 / 605 |
| bladder | 100% | 8323.81 | 21 / 21 | 100% | 71.86 | 502 / 504 |
| breast | 100% | 8794.58 | 459 / 459 | 99% | 74.86 | 1110 / 1118 |
| brain | 99% | 5364.24 | 2620 / 2642 | 100% | 82.52 | 705 / 705 |
| kidney | 100% | 5386.12 | 89 / 89 | 99% | 51.73 | 892 / 901 |
| adrenal gland | 100% | 9875.17 | 258 / 258 | 98% | 61.89 | 226 / 230 |
| liver | 100% | 3343.04 | 226 / 226 | 98% | 38.84 | 396 / 406 |
| adipose | 100% | 9216.89 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 9046.21 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 100% | 69.08 | 80 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 84.33 | 29 / 29 |
| spleen | 100% | 7773.05 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 82.19 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 31.40 | 1 / 1 |
| muscle | 100% | 4414.69 | 802 / 803 | 0% | 0 | 0 / 0 |
| heart | 99% | 4837.80 | 852 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 90% | 5398.95 | 837 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006954 | Biological process | inflammatory response |
| GO_0006397 | Biological process | mRNA processing |
| GO_0070935 | Biological process | 3'-UTR-mediated mRNA stabilization |
| GO_0032496 | Biological process | response to lipopolysaccharide |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_1990904 | Cellular component | ribonucleoprotein complex |
| GO_0045202 | Cellular component | synapse |
| GO_0005634 | Cellular component | nucleus |
| GO_0019901 | Molecular function | protein kinase binding |
| GO_0003729 | Molecular function | mRNA binding |
| GO_0035925 | Molecular function | mRNA 3'-UTR AU-rich region binding |
| GO_0003723 | Molecular function | RNA binding |
| Gene name | HNRNPA0 |
| Protein name | Heterogeneous nuclear ribonucleoprotein A0 (hnRNP A0) |
| Synonyms | HNRPA0 |
| Description | FUNCTION: mRNA-binding component of ribonucleosomes. Specifically binds AU-rich element (ARE)-containing mRNAs. Involved in post-transcriptional regulation of cytokines mRNAs. . |
| Accessions | ENST00000314940.7 Q13151 |